| [1] | WATKINS LR, HUTCHINSON MR, RICE KC, et al. The 'toll' of opioid-induced glial activation: improving the clinical efficacy of opioids by targeting glia[J]. Trends Pharmacol Sci, 2009, 30(11): 581. doi: 10.1016/j.tips.2009.08.002 |
| [2] | PYONTECK SM, AKKARI L, SCHUHMACHER AJ, et al. CSF-1R inhibition alters macrophage polarization and blocks glioma progression[J]. Nat Med, 2013, 19(10): 1264. doi: 10.1038/nm.3337 |
| [3] | GUAN Z, KUHN JA, WANG X, et al. Injured sensory neuron-derived CSF1 induces microglial proliferation and DAP12-dependent pain[J]. Nat Neurosci, 2016, 19(1): 94. doi: 10.1038/nn.4189 |
| [4] | ZHAO CM, GUO RX, HU F, et al. Spinal MCP-1 contributes to the development morphine antinociceptive tolerance in rats[J]. Am J Med Sci, 2012, 344(6): 473. doi: 10.1097/MAJ.0b013e31826a82ce |
| [5] | ELMORE MR, NAJAFI AR, KOIKE MA, et al. Colony-stimulating factor 1 receptor signaling is necessary for microglia viability, unmasking a microglia progenitor cell in the adult brain[J]. Neuron, 2014, 82(2): 380. doi: 10.1016/j.neuron.2014.02.040 |
| [6] | MILLIGAN ED, WATKINS LR. Pathological and protective roles of glia in chronic pain[J]. Nat Rev Neurosci, 2009, 10(1): 23. doi: 10.1038/nrn2533 |
| [7] | LIU L, COLLER JK, WATKINS LR, et al. Naloxone-precipitated morphine withdrawal behavior and brain IL-1β expression: comparison of different mouse strains[J]. Brain Behav Immun, 2011, 25(6): 1223. doi: 10.1016/j.bbi.2011.03.016 |
| [8] | SONG P, ZHAO ZQ. The involvement of glial cells in the development of morphine tolerance[J]. Neurosci Res, 2001, 39(3): 281. doi: 10.1016/S0168-0102(00)00226-1 |
| [9] | LEE SH, SHI XQ, FAN A, et al. Targeting macrophage and microglia activation with colony stimulating factor 1 receptor inhibitor is an effective strategy to treat injury-triggered neuropathic pain[J]. Mol Pain, 2018, 14: 1744806918764979. |